Full Text View
Tabular View
Study Results
Related Studies
Efficacy and Safety of Lubiprostone in Patients With Irritable Bowel Syndrome With Constipation
This study has been completed.
Study NCT00399542   Information provided by Sucampo Pharmaceuticals, Inc.

First Received on November 13, 2006.   Last Updated on June 2, 2010   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Irritable Bowel Syndrome
Constipation
More general conditions related to this trial
Colonic Diseases
Colonic Diseases, Functional
Digestive System Diseases
Gastrointestinal Diseases
Intestinal Diseases
Signs and Symptoms
Signs and Symptoms, Digestive
Interventions listed in this trial
Lubiprostone
Placebo
Sponsors listed in this trial
Sucampo Pharmaceuticals, Inc.
Takeda Pharmaceutical Company Limited


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services